71 related articles for article (PubMed ID: 24891170)
1. Update on medullary thyroid cancer.
Hu MI; Ying AK; Jimenez C
Endocrinol Metab Clin North Am; 2014 Jun; 43(2):423-42. PubMed ID: 24891170
[TBL] [Abstract][Full Text] [Related]
2. Emerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches.
Harris PJ; Bible KC
Expert Opin Investig Drugs; 2011 Oct; 20(10):1357-75. PubMed ID: 21910667
[TBL] [Abstract][Full Text] [Related]
3. Overview and management of dermatologic events associated with targeted therapies for medullary thyroid cancer.
Lacouture ME; Ciccolini K; Kloos RT; Agulnik M
Thyroid; 2014 Sep; 24(9):1329-40. PubMed ID: 24902006
[TBL] [Abstract][Full Text] [Related]
4. Medullary thyroid cancer: an introduction.
Gupta MK
Curr Oncol; 2019 Oct; 26(5):294. PubMed ID: 31708647
[No Abstract] [Full Text] [Related]
5. Medullary thyroid cancer: an update for surgeons.
Azar FK; Lee SL; Rosen JE
Am Surg; 2015 Jan; 81(1):1-8. PubMed ID: 25569037
[TBL] [Abstract][Full Text] [Related]
6. Management of advanced medullary thyroid cancer.
Hadoux J; Pacini F; Tuttle RM; Schlumberger M
Lancet Diabetes Endocrinol; 2016 Jan; 4(1):64-71. PubMed ID: 26608066
[TBL] [Abstract][Full Text] [Related]
7. Advances in thyroid cancer treatment: latest evidence and clinical potential.
Alonso-Gordoa T; Díez JJ; Durán M; Grande E
Ther Adv Med Oncol; 2015 Jan; 7(1):22-38. PubMed ID: 25553081
[TBL] [Abstract][Full Text] [Related]
8. Effect of Two Ginger Varieties on Arginase Activity in Hypercholesterolemic Rats.
Akinyemi AJ; Oboh G; Ademiluyi AO; Boligon AA; Athayde ML
J Acupunct Meridian Stud; 2016 Apr; 9(2):80-7. PubMed ID: 27079229
[TBL] [Abstract][Full Text] [Related]
9. Is ginger beneficial for nausea and vomiting? An update of the literature.
Marx W; Kiss N; Isenring L
Curr Opin Support Palliat Care; 2015 Jun; 9(2):189-95. PubMed ID: 25872115
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathology of hereditary and sporadic medullary thyroid carcinomas.
Chernock RD; Hagemann IS
Am J Clin Pathol; 2015 Jun; 143(6):768-77. PubMed ID: 25972318
[TBL] [Abstract][Full Text] [Related]
11. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Wells SA; Asa SL; Dralle H; Elisei R; Evans DB; Gagel RF; Lee N; Machens A; Moley JF; Pacini F; Raue F; Frank-Raue K; Robinson B; Rosenthal MS; Santoro M; Schlumberger M; Shah M; Waguespack SG;
Thyroid; 2015 Jun; 25(6):567-610. PubMed ID: 25810047
[TBL] [Abstract][Full Text] [Related]
12. Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectives.
Ceolin L; Duval MADS; Benini AF; Ferreira CV; Maia AL
Endocr Relat Cancer; 2019 Aug; 26(9):R499-R518. PubMed ID: 31252403
[TBL] [Abstract][Full Text] [Related]
13. The Establishment and Verification of a Nomogram Model for Predicting the Overall Survival of Medullary Thyroid Carcinoma: An Analysis Based on the SEER Database.
Wang W; Wang X; Che G; Qiao J; Chen Z; Liu J
Curr Oncol; 2023 Dec; 31(1):84-96. PubMed ID: 38248091
[TBL] [Abstract][Full Text] [Related]
14. Lobectomy may be more appropriate for patients with early-stage medullary thyroid cancer older than 60 years old.
Yang B; Niu G; Li X; Ma F; Ma Y; Hu S
Front Endocrinol (Lausanne); 2022; 13():1015319. PubMed ID: 36339396
[TBL] [Abstract][Full Text] [Related]
15. Medullary thyroid cancer: molecular factors, management and treatment.
Pavlidis E; Sapalidis K; Chatzinikolaou F; Kesisoglou I
Rom J Morphol Embryol; 2020; 61(3):681-686. PubMed ID: 33817709
[TBL] [Abstract][Full Text] [Related]
16. Correlation of molecular data with histopathological and clinical features in a series of 66 patients with medullary thyroid carcinoma.
Moura MM; Cabrera RA; Esteves S; Cavaco BM; Soares P; Leite V
J Endocrinol Invest; 2021 Sep; 44(9):1837-1846. PubMed ID: 33575974
[TBL] [Abstract][Full Text] [Related]
17. Quantitative Proteomics Analysis of Sporadic Medullary Thyroid Cancer Reveals FN1 as a Potential Novel Candidate Prognostic Biomarker.
Zhan S; Li J; Wang T; Ge W
Oncologist; 2018 Dec; 23(12):1415-1425. PubMed ID: 29739896
[TBL] [Abstract][Full Text] [Related]
18. CXCR4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma.
Werner TA; Forster CM; Dizdar L; Verde PE; Raba K; Schott M; Knoefel WT; Krieg A
Br J Cancer; 2017 Dec; 117(12):1837-1845. PubMed ID: 29112684
[TBL] [Abstract][Full Text] [Related]
19. A large Chinese pedigree of multiple endocrine neoplasia type 2A with a novel C634Y/D707E germline mutation in
Lu F; Chen X; Bai Y; Feng Y; Wu J
Oncol Lett; 2017 Sep; 14(3):3552-3558. PubMed ID: 28943896
[TBL] [Abstract][Full Text] [Related]
20. Medullary Thyroid Cancer: Clinical Characteristics and New Insights into Therapeutic Strategies Targeting Tyrosine Kinases.
Rajabi S; Hedayati M
Mol Diagn Ther; 2017 Dec; 21(6):607-620. PubMed ID: 28698976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
